Table 2.

Survival Outcomes by Patient

	Stage	BRAF Mutation	Overall Survival, mos	Survival After Metastasis, mos
1	IA	V600E	90.0a	45.4a
2	IIIB	V600E	8.9	2.3
3	IV	G469A	37.7	37.7
4	IIIB	V600E	40.3a	26.8a
5	IIIA	G469A	41.7	27.7
6	IV	V600E	14.0	14.0
7	IV	V600E	132.6	132.6
8	IIA	V600E	66.2	NA
9	IV	V600E	1.8	1.8
10	IV	V600E	48.2	48.2
11	IIIA	G466V	40.1	33.0
12	IA	V600E	37.0a	NA
13	IV	V600_W604delinsR	22.7a	22.7a
14	IV	V600E	28.1	28.1
15	IV	V600E	13.7	13.7
16	IV	V600E	89.8	89.8
17	IV	K601E	6.2	6.2
18	IV	V600E	19.6	19.6

^aDenotes patients who had no recorded date of death beyond their last follow-up encounter or who were still alive as of December 31, 2017.